HemoGenyx London, UK
Breakthrough therapies for the treatment of blood diseases.
Y1 (2015) Life Sciences EXITOur companies have collectively raised nearly $1 billion in capital, with a unicorn and a publicly traded company among the ranks.
Sort by:
Showing 1 of 1 items
Breakthrough therapies for the treatment of blood diseases.
Y1 (2015) Life Sciences EXIT